Objective-Transient receptor potential melastatin-2 (TRPM2) channel is a nonselective cation channel that mediates influx of Ca 2+ and Na + with relative permeability of PCa:PNa ≈0.6 in response to cellular oxidative stress. As angiogenesis and ischemic neovascularization are both significantly dependent on oxidant signaling, here we investigated the possible role of vascular endothelial growth factor (VEGF)-induced reactive oxygen species production in activating TRPM2dependent Ca 2+ signaling and in the mechanism of angiogenesis and ischemic neovascularization. Approach and Results-We observed that VEGF stimulation rapidly induced the association of TRPM2 and cellular Src kinase with vascular endothelial-cadherin forming a signalplex at vascular endothelial-cadherin junctions in endothelial cells. Using endothelial cells isolated from TRPM2 −/− mice or after small interfering RNA depletion of TRPM2, we demonstrated that TRPM2-activated Ca 2+ signaling was required for cellular Src kinase-induced phosphorylation of vascular endothelial-cadherin at Y658 and Y731, the crucial sites involved in vascular endothelial-cadherin internalization in response to VEGF. VEGF-induced reactive oxygen species generation activated TRPM2-induced Ca 2+ entry, whereas the reactive oxygen species-insensitive TRPM2 mutant (C1008→A) showed impaired Ca 2+ entry. Endothelial cells depleted of TRPM2 also displayed significantly perturbed migratory phenotype and impaired activation of cellular Src in response to VEGF. TRPM2 −/− mice reconstituted with wild-type myeloid cells demonstrated aberrant angiogenesis and neovascularization in the hindlimb ischemia model as compared with wild-type mice.
T he growth of blood vessels induced by vascular endothelial growth factor (VEGF) ligation of the receptor VEFGR2 is mediated by an array of parallel and complementary signaling pathways. 1 In postnatal life angiogenesis and arteriogenesis are the major determinants of blood vessel growth. 2 Sprouting of new vessels is defined as angiogenesis, 2 whereas arteriogenesis is defined by enlargement and remodeling of existing collateral arteries and formation of conductance vessels. 2 Neovascularization in response to persistent ischemia is a fundamental adaptive response encompassing features of both angiogenesis and arteriogenesis. 2, 3 Neovascularization in the ischemic milieu is largely driven by the recruitment endothelial cells (ECs) and inflammatory cells and generation of reactive oxygen species (ROS) and growth factors such as VEGF. 4, 5 The canonical growth factor VEGF after binding to VEGFR2 induces EC migration, recruitment, and proliferation. 6 The stability of vascular endothelial (VE)-cadherin homotypic interaction at adherens junctions (AJs) is maintained by its association with cytoplasmic catenin proteins α-, β-, γ-, and p120-catenins, which anchor VE-cadherin to the actin cytoskeleton. 7 AJ disassembly induced by VEGF signaling is essential in initiating the angiogenesis program. 8 In this context, the phosphorylation of Y658 and Y731 in the C-terminal of VE-cadherin prevented VE-cadherin interaction with catenins and was responsible for disassembly of AJs and thereby facilitated the migration of ECs. [9] [10] [11] Although VEGF-induced Y658 and Y731 phosphorylation of VE-cadherin occurs as a consequence of generation of ROS, 12 the signaling mechanisms downstream of ROS signaling are not understood. Studies have shown that VEGF-induced ROS generated by activation of NADPH oxidase homolog 2 (NOX2) mediates angiogenesis and neovascularization of ischemic tissue. 13, 14 In addition to ROS, Ca 2+ signaling activated by VEGF is also crucial in the mechanism of EC migration and angiogenesis. 15, 16 Here, we addressed the question whether ROS generation downstream of VEGF signaling activates Ca 2+ signaling via the ROS-activated transient receptor potential melastatin 2 (TRPM2) channel, a member of the transient receptor potential melastatin family, 17 and whether TRPM2-activated Ca 2+ signaling is a prerequisite for angiogenesis and ischemic neovascularization.
TRPM2 is highly expressed in ECs where it mediates redoxactivated Ca 2+ entry and participates in increasing endothelial permeability in response to oxidants. 17 The primary mode of TRPM2 activation is through oxidant-induced generation of ADP-ribose (ADPR), 18 which binds to the Nudix box domain (NUDT9-H) in TRPM2 C-terminal. 19 Oxidants enzymatically convert NAD + to ADPR through poly ADPR polymerase. 18 We demonstrated that VEGF acted via the generation of ROS activated TRPM2, resulting in Ca 2+ signaling and cellular Src (c-Src) kinase activation, and subsequently induced VE-cadherin phosphorylation on Y658 and Y731. We showed, importantly, that ROS activation of TRPM2 in mice was required for mediating angiogenesis and ischemic neovascularization.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

VEGF Activates ROS-Dependent Ca 2+ Influx via TRPM2 Channel
We first studied whether VEGF-induced ROS production could activate TRPM2 channels expressed in ECs. We observed by 2′,7′-dichlorfluorescein-diacetate fluorescence and the more specific Amplex Red assay 20 that VEGF indeed induced ROS production in ECs ( Figure 1A ; Figure IA in the online-only Data Supplement) as expected. 12 In addition, VEGF induced Ca 2+ transients in ECs, which were in part inhibited by the Nonstandard Abbreviations and Acronyms 3ABA 3-aminobenzamide ADPR
ADP-ribose
AJs adherens junctions general NADPH oxidase blocker apocynin ( Figure 1B ) or polyethylene glycol catalase ( Figure IB in the online-only Data Supplement). The TRPM2 inhibitor 3-aminobenzamide (3ABA), which antagonizes poly ADPR polymerase activity responsible for generating the TRPM2 agonist ADPR, 17,21 also suppressed Ca 2+ transients ( Figure 1B) . In contrast, expression of the ROS-insensitive mutant of TRPM2 C1008→A in ECs reduced VEGF-mediated Ca 2+ entry 22 ( Figure 1C ). VEGF-induced Ca 2+ influx was also reduced in ECs from TRPM2 −/− mice as compared with ECs from wild-type (WT) mice ( Figure IC in the online-only Data Supplement).
VEGF Induces the Association of TRPM2 With c-Src and VE-Cadherin
We next addressed possible signaling mechanisms downstream of TRPM2 activation by first determining whether VEGF elicited interaction of c-Src with TRPM2 based on the role of Src activity in promoting disassembly of AJs and hence angiogenesis. 23 Interestingly, immunoprecipitation studies showed that VEGF stimulation within 3 minutes induced c-Src binding to TRPM2 (Figure 2A ). In addition, TRPM2 interacted with VE-cadherin, with maximum occurring at 10 minutes after VEGF stimulation ( Figure 2A ). We next used the Duolink proximity ligation assay 24 to monitor in situ formation of c-Src-TRPM2-VE-cadherin complex. In unstimulated ECs, protein interactions were not seen. However, at 3 minutes after VEGF stimulation, we observed TRPM2 and c-Src interaction with VE-cadherin at AJs as well as other sites in ECs ( Figure 2B ). This interaction was prominent at 10 minutes and persisted up to 30 minutes ( Figure 2B A, Coimmunoprecipitation studies. VE-cadherin was immunoprecipitated from cell lysates with anti-VE-cadherin antibody after VEGF stimulation. TRPM2 was detected using anti-TRPM2 antibody. VEGF induced association of TRPM2 with VE-cadherin with maximum response at 30 minutes. TRPM2 was also immunoprecipitated with anti-TRPM2 antibody after VEGF stimulation and was immunoblotted using the anti-c-Src antibody. Association of c-Src with TRPM2 was observed within 3 minutes after VEGF stimulation. Thick bands denote IgG heavy chains; 10% of the original cell lysate was blotted as input control. The experiment was independently reproduced twice. B, In situ proximal ligation assay (PLA) in endothelial cells (ECs) treated with VEGF at the indicated times. Primary mouse (c-Src) and rabbit (TRPM2) antibodies were combined with secondary PLA probes (Olink Bioscience). The interaction events are visible as red dots, nuclear staining in blue (4′,6-diamidino-2-phenylindole), and endothelial junctions are stained with VE-cadherin (green). In another PLA experiment, interaction between TRPM2 and VE-cadherin was determined using primary rabbit (TRPM2) and goat (VE-cadherin) antibodies combined with secondary with PLA probes. The interaction is visible as red dots and endothelial junctions are stained with p120-catenin (green). Scale bar=25 μm. The experiment was repeated twice with similar observations. IP indicates immunoprecipitation.
immunoprecipitation and proximity ligation assays showed essentially similar VEGF-induced formation of a tripartite complex consisting of TRPM2 and c-Src at first which was then followed by binding of both to VE-cadherin.
TRPM2 Activation of c-Src Signals VE-Cadherin Phosphorylation and EC Migration
We next studied the function of VEGF-induced binding of TRPM2 and c-Src with VE-cadherin at AJs. Here, we observed that c-Src was phosphorylated at the Y-416 active site 25 in a TRPM2-dependent manner ( Figure 3A ). c-Src activation in turn also induced the phosphorylation of VE-cadherin ( Figure 3B and 3C). Depletion of either TRPM2 or c-Src suppressed phosphorylation of VE-cadherin at Y658 and Y731 ( Figure 3B and 3C). TRPM2 depletion, however, had no effect on VEGFR2 activation itself based on the finding that phosphorylation of VEGFR2 on the active site Y1175 was not affected ( Figure Next studies were made using ECs obtained from TRPM2 −/− mice. These studies showed that ECs obtained from TRPM2 −/− mice were resistant to VEGF-induced phosphorylation at Y658 and T731, in contrast to WT ECs ( Figure 3D ). In addition, using 2 different poly ADPR polymerase inhibitors 3,4-dihydro-5[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinoline and 3ABA, 17 we observed that both inhibitors interfered with VEGF signaling as evident by markedly reduced VEGFinduced phosphorylation of VE-cadherin ( Figure 3E ). These findings together demonstrate the key involvement of TRPM2 in the signaling pathway mediating VE-cadherin phosphorylation downstream of VEGF signaling.
We next addressed whether ROS generation downstream of VEGF signaling was also required for TRPM2 activation. Inhibiting VEGF-induced ROS generation by apocynin or more selectively through small interfering RNA depletion of NOX2 in ECs suppressed VE-cadherin phosphorylation at Y658 and Y731 ( Figure 3F ; Figure VA in the online-only Data Supplement). VEGF exposure of ECs expressing the ADPR-insensitive mutant of TRPM2 C1008→A also suppressed VE-cadherin phosphorylation at Y658 and Y731 ( Figure 3G ). These findings thus link ROS generation to activation of TRPM2 and thereby to VE-cadherin phosphorylation at Y658 and Y731 sites. 11 We also observed that blocking intracellular Ca 2+ influx by LaCl 3 abrogated c-Src activation and VE-cadherin phosphorylation highlighting the essential role of Ca 2+ influx in signaling c-Src-induced VE-cadherin phosphorylation ( Figure VB in the online-only Data Supplement).
VEGF mediates internalization of VE-cadherin secondary to decreased p120-catenin and β-catenin binding to VE-cadherin, which in turn promotes the migration of ECs. 26 We observed in control ECs that VEGF significantly reduced the expression of p120-catenin and β-catenin at AJs consistent with internalization of VE-cadherin, whereas the response was significantly attenuated in ECs from TRPM2 −/− mice ( Figure 4A and 4B). These changes were correlated with attenuated decrease in transendothelial resistance in TRPM2-depleted ECs after VEGF stimulation as compared with control ECs ( Figure 4C ). VEGF-induced actin stress fiber formation was also reduced in TRPM2-depleted ECs as compared with controls ( Figure  VI in the online-only Data Supplement).
We next determined the role of TRPM2 in mediating the EC migration using the transendothelial resistance wound scratch assay. 27 A wound was created in EC monolayers growing on microelectrodes by applying a calibrated electric field. 27 This resulted in 80% decrease in transendothelial resistance ( Figure 4D and 4E ). In controls, EC migration showed full recovery at 8 to 10 hours after wound. These migration and recovery responses were, however, significantly impaired after TRPM2 or c-Src depletion in ECs ( Figure 4D and 4E). The validity of these migration results was confirmed by wound scratch healing assay ( Figure 4F ).
TRPM2 Is Required for Angiogenesis and Postischemic Neovascularization
To investigate the role of TRPM2 in the mechanism of angiogenesis in vivo, WT and TRPM2 −/− mice were injected subcutaneously with Matrigel plugs supplemented with VEGF (100 ng/mL). The plugs obtained from TRPM2 −/− mice showed a significantly reduced CD31 + vessel formation ( Figure 5A and 5B) and angiogenic area compared with WT mice ( Figure 5C ). Using the mouse aortic ring assay, 28 we also observed defective capillary sprouting and reduced capillary lengths from TRPM2 −/− mouse rings as compared with WT mice ( Figure 5D -5F).
To extend these studies to an in vivo ischemia model, we used the mouse model of hindlimb ischemia. 4, 5, 13, 14 The lethally irradiated TRPM2 −/− mice were reconstituted with WT bone marrow cells 5 to determine the role of EC as opposed to myeloid cell-expressed TRPM2 in mediating postischemia neovascularization. The control group consisted of WT mice similarly irradiated and transplanted with WT bone marrow cells. Laser Doppler blood flow measurements in ischemic and nonischemic limbs after femoral artery ligation demonstrated that hindlimb blood flow was markedly reduced after femoral artery ligation compared with the nonischemic control (day 0), and importantly blood flow recovered to 60% of basal level by day 28 in WT mice ( Figure 6A ). However, blood flow recovery was severely compromised in TRPM2 −/− mice ( Figure 6A ). In the bone marrow transplantation experiments, the effectiveness in TRPM2 −/− mice was confirmed by determining TRPM2 protein expression in bone marrow cells isolated from chimeric TRPM2 −/− mice ( Figure 6B ).
We additionally analyzed alterations in arteriogenesis in the adductor muscle of WT and TRPM2 −/− mice. Here, we measured wall thickness and lumen diameter of arterial vessels. Both the lumen diameter and the wall thickness of vessels were significantly lower in TRPM2 −/− mice than in WT mice after ischemic injury ( Figure 6C-6E ). In addition, depletion of TRPM2 in ECs suppressed VEGF-induced extracellular signal-regulated kinase phosphorylation ( Figure VIIA A, Immunofluorescent staining of p120catenin (green) and β-catenin (red) in mouse lung endothelial cells (ECs). VEGF stimulation induced multiple discontinuities in the expression of p120-catenin and β-catenin at the plasma membrane in wild-type ECs (arrows), whereas these changes were reduced in TRPM2 −/− mouse ECs and adherens junctions (AJs) seemed continuous. Scale bar=20 μm. B, Bar graph of mean fluorescent intensities at AJs in wild-type and TRPM2 −/− ECs show significantly reduced intensity of p120catenin (left) and β-catenin (right) in WT ECs compared with TRPM2 −/− ECs. Mean fluorescent intensity (MFI) was calculated from images taken from 5 to 6 different fields for each group. The mean response from 2 independent experiments is shown in the bar graph. *P<0.05. C, Transendothelial resistance (TER) measurement of AJ disassembly (with SEM bars) in control and TRPM2-depleted human pulmonary artery ECs. Small interfering RNA (siRNA) depletion of TRPM2 suppressed AJ disassembly induced by VEGF. Representative tracings are shown. The mean response after VEGF stimulation is shown in bar graph from 2 independent experiments each consisting of 4 replicates. D and E, EC migration measured using TER showing markedly reduced EC migration after VEGF stimulation in siRNA TRPM2depleted or siRNA cellular Src (c-Src)depleted ECs compared with control ECs. Study was made after uniform injury of EC monolayers made at the arrow. Each trace is representative of ≥5 replicates. The mean response is shown for n=3 for TRPM2 siRNA and n=2 for c-Src siRNA. F, Wound scratch healing motility assay performed ≈18 hours showed that human ECs transfected with TRPM2 siRNA and c-Src siRNA exhibited impairment in wound closure as compared with control siRNA-treated human ECs. Experiment was repeated twice. Bar=50 μm.
In addition, ischemic angiogenesis was evaluated in the gastrocnemius muscle of WT and chimeric TRPM2 −/− mice. Capillaries visualized by staining with anti-CD31 antibody were counted in ischemic regions ( Figure 6F-6H ). Mean number of CD31 + capillaries after ischemia in WT mice was 1336±90/mm 2 compared with 591±141 in TRPM2 −/− mice ( Figure 6G ). There were also significantly fewer α-smooth muscle actin (SMA + ) arterioles in TRPM2 −/− mice compared with WT mice (WT 189±29 versus TRPM2 −/− 119±23; Figure  6G and 6H). The expression of TRPM2 was localized in the endothelium and vascular smooth muscle cells of arteries in gastrocnemius muscle ( Figure 6I ; Figure online-only Data Supplement) and in macrophages with Mac-3, a marker of macrophages ( Figure VIIB in the online-only Data Supplement). Interestingly, the newly formed capillaries at day 28 of postischemic injury showed strong expression of TRPM2 suggesting possible role of TRPM2 in driving the postischemic flow recovery ( Figure 6I ).
Discussion
Neovascularization is an adaptive response in ischemic vascular disorders 30 that is co-ordinated by 2 distinct processes: angiogenesis involving proliferation of ECs and extension of the capillary network and arteriogenesis involving outgrowth of collateral arteries and de novo arterialization. 2, 31 Both are driven by VEGF but require distinct signaling pathways. 2 Here, we demonstrated the novel role of the ROS-activated TRPM2 channel in activating c-Src kinase, which thereby mediated VEGF-induced postischemic neovascularization through induction of both angiogenesis and arteriogenesis. The following key observations support this conclusion. First, we observed that TRPM2 deficiency severely impaired VEGF-induced EC migration, angiogenesis, and arteriogenesis resulting in defective ischemic neovascularization in the standardized mouse hindlimb ischemia model. Second, VEGF signaling induced the association of c-Src and TRPM2 with VE-cadherin at AJs, forming a tripartite complex. Third, c-Src activation occurring downstream of TRPM2-activated Ca 2+ signaling was responsible for phosphorylating VE-cadherin at Y658 and Y731, the specific phospho-switches responsible for VE-cadherin internalization and EC migration, 11, 12, 26 and resulting in neovascularization. 8 Although our focus was on TRPM2, we cannot rule out the possibility that additional ROS-sensitive trp channels expressed in ECs, such as TRPC3 and TRPC4, 32, 33 may also be involved in mediating neovascularization. However, of these channels TRPM2 is specialized based on the ROS-dependent mechanism of activation involving generation of the messenger ADPR. 19 We observed that ADPR-induced activation of TRPM2 increased endothelial permeability secondary to Ca 2+ influx. 17 The present results provide compelling evidence that TRPM2 channel activation is required for EC migration and the formation of new blood vessels.
We observed that VEGF signaling mediated the formation of a tripartite complex consisting of TRPM2 and c-Src associating with VE-cadherin, which was required for c-Src phosphorylation of VE-cadherin at Y658 and Y731. Formation of this complex was a prerequisite for activation of TRPM2-dependent angiogenesis and neovascularization. This mechanism fits well with the proposed scaffold function of VE-cadherin in aggregating essential signaling constituents such as Gα13 that regulate assembly and disassembly of AJs. 34, 35 Thus, VE-cadherin in addition to its role as an adhesive protein mediating formation of a confluent EC monolayer also has the ability to assemble TRPM2 and c-Src on AJs that are essential for induction of the angiogenesis and arteriogenesis programs.
Phosphorylation of VE-cadherin at Y658 proximal to the binding site for p120-catenin prevented p120-catenin binding to VE-cadherin and enabled the internalization of VE-cadherin and subsequent disassembly of AJs. 11, 26 In addition, phosphorylation of Y-731 prevented the binding of β-catenin to VE-cadherin also promoting the loss of VE-cadherin junctional integrity. 36 We observed that VEGF-induced phosphorylation of VE-cadherin was suppressed at both Y658 and Y731 by TRPM2 depletion and in ECs isolated from TRPM2 −/− mice. In addition, internalization of p120-catenin and β-catenin from AJs was reduced in TRPM2 −/− ECs as compared with WT ECs consistent with the VE-cadherin phosphorylation results. A similar VE-cadherin tyrosine phosphorylation was observed in ECs associated with rapid angiogenesis in ovaries and uterus and ECs from tumor vessels. 9, 37 Phosphodefective Y658 VE-cadherin mutant was preferentially localized at AJs and these ECs also failed to migrate properly. 11, 26, 36 In another study, mice having EC-specific deletion of phosphotyrosine phosphatase 1b, which functions to stabilize VE-cadherin junctions, showed enhanced EC migration, capillary sprouting, and accelerated blood flow recovery after femoral artery ligation. 38, 39 Thus, our results showing that VE-cadherin phosphorylation at Y658 and Y731 was c-Src dependent and occurred downstream of TRPM2 activation are consistent with the concept that VE-cadherin phosphorylation at these sites is a prerequisite for EC migration and thereby new vessel growth.
We observed that depletion of TRPM2 prevented the phosphorylation of c-Src at the Y416 active site, indicating that TRPM2 was required for c-Src activation. A likely mechanism of c-Src activation in this case is through ROS-mediated inactivation of tyrosine phosphatase Src homology 2 (SH2) domain containing phosphatase (SHP-2) that occurs secondary to oxidation of a cysteine residue in SHP-2's catalytic domain. 40, 41 We also observed that ECs expressing an ADPR-insensitive mutant of TRPM2 (C1008→A) or pharmacological inhibition of TRPM2 with 3ABA suppressed Ca 2+ entry as well as VE-cadherin phosphorylation in response to VEGF. Although Ca 2+ influx was only partially reduced in these experiments, it is possible that a subthreshold level of Ca 2+ influx was insufficient to phosphorylate VE-cadherin. The concentrations of inhibitors used for 3ABA or apocynin were based on previous observations and had no cytotoxic effects, 42, 43 although with inhibitor studies we cannot always rule out certain nonspecific effects. Although our findings point to the key role of TRPM2-mediated Ca 2+ entry in mediating c-Src activation, it remains unclear how TRPM2-induced Ca 2+ influx activates c-Src at the level of VE-cadherin junctions. One possibility is that TRPM2-mediated Ca 2+ entry facilitates the inactivation of phosphatases such as SHP-2 and phosphotyrosine phosphatase 1b through enhanced oxidant generation. 44, 45 EC-derived H 2 O 2 was required for neovascularization in response to ischemia. 4 Mice deficient in NOX2 also exhibited significantly delayed blood flow recovery and defective capillary formation. 13 EC-specific NOX4 overexpressing transgenic mice showed enhanced ischemia-induced angiogenesis. 46 The present findings reinforce the essential role of ROS generation by ECs in signaling angiogenesis and ischemic neovascularization; however, our findings interpose the requisite role of ROS activation of TRPM2 as a fundamental mechanism of ROS signaling-mediated angiogenesis and ischemic neovascularization.
Ligation of the femoral artery in mice induces ischemic angiogenesis as well as arteriogenesis of collateral arteries. 3 Angiogenesis in this model has a limited capacity to increase perfusion of ischemic tissue. 47 The major part of reperfusion after ischemic injury is mediated by arteriogenesis. 47 TRPM2 −/− mice exhibited marked defects in both angiogenesis and arteriogenesis as indicated by reduced formation of CD31 + capillaries and α-SMA + arterial vessels of gastrocnemius muscle as well as reduced collateral vessel formation in the hindlimb. Thus, TRPM2-activated signaling seems to be important for both angiogenesis and arteriogenesis. An impairment in extracellular signal-regulated kinase activation has been implicated in arterial morphogenesis. 29 In this regard in the present study, the observed suppressed extracellular signal-regulated kinase activation after TRPM2 knockdown may underlie the arteriogenic defect seen in TRPM2 −/− mice.
We also observed enhanced expression of TRPM2 in small capillaries at days 14 and 28 after onset of ischemia raising the intriguing possibility that upregulation of TRPM2 in itself is an adaptive response to prolonged ischemia.
The recruitment of inflammatory myeloid cells is important for postischemic angiogenesis and neovascularization. 5 As TRPM2 was shown to negatively regulate ROS generation in myeloid cells and thereby to modulate inflammation, 48 it is possible that this function of TRPM2 influenced the formation of vessels after ischemia. To rule out the role of heightened activation of TRPM2 −/− inflammatory myeloid cells in the mechanism of angiogenesis and neovascularization, we performed studies by reconstituting the TRPM2 −/− mice with WT myeloid cells, which clearly showed that myeloid cells were not involved.
Based on the finding that TRPM2 induces a rise in intracellular Ca 2+ that can activate the apoptosis program, 49 an important question in the present study is the extent to which TRPM2 activation induced by ROS generation mediates apoptosis. Any apoptosis would counteract revascularization induced by TRPM2. However, Ca 2+ -mediated apoptosis occurred at >4-fold higher threshold of Ca 2+ signaling than induced by VEGF and required greater ROS generation than seen in the present studies. 49 In summary, TRPM2 activated by VEGF-induced ROS generation and the resulting activation of c-Src was required for angiogenesis and postischemic neovascularization in mice as described in Figure 7 . Transient receptor potential melastatin-2 (TRPM2) is a Reactive oxygen species-sensitive calcium channel, which is highly expressed in endothelial cells and has been implicated in increasing endothelial permeability in response to oxidants. However, the role of TRPM2 in angiogenesis has not been explored. The studies presented here provide compelling evidence that TRPM2 plays an important role in ischemic neovascularization by promoting endothelial cell migration after cellular Src kinase activation. To define the TRPM2's proangiogenic function in ECs, studies were made in cultured ECs as well as TRPM2 −/− mice. In cultured ECs, vascular endothelial growth factor induced the formation of a signalplex consisting of TRPM2 and cellular Src kinase localized on vascular endothelial (VE)-cadherin junctions. These studies provide novel insights of the heretofore unknown role of TRPM2 in mediating angiogenesis and arteriogenesis with the potential of developing novel therapeutics for reperfusion of ischemic disease.
Significance
